Document is current

Article History

Received: 28 October 2020

Revised: 14 December 2020

Accepted: 17 December 2020

First Online: 19 January 2021

Compliance with ethical standards

:

: All the authors have received honoraria for participating in EMAS from Novartis Pharma AG.Dr. Denis Poddubnyy has received unrelated research grants from Abbvie, Lilly, MSD, Novartis, and Pfizer, and unrelated honoraria from Abbvie, BMS, Celgene, Lilly, MSD, Novartis, Pfizer, Roche, and UCB.Dr. Laure Gossec has received unrelated research grants from BMS, Lilly, and Pfizer and unrelated honoraria from Abbvie, BMS, Celgene, Janssen, Lilly, Novartis, MSD, Pfizer, and UCB.Dr. Christine Bundy has received unrelated honoraria from Abbvie, Celgene, Janssen, Lilly, Novartis, and Pfizer.Mrs. Souzi Makri has received unrelated honoraria or research grants from Bayer, GSK, Novartis and Pfizer.Dr. Carlos Delgado Domínguez has received unrelated honoraria from Novartis.Dr. Victoria Navarro-Compán has received unrelated honoraria or research grants from Abbvie, BMS, Lilly, MSD, Novartis, Pfizer, Roche, and UCB.

: The manuscript does not contain clinical studies.

: All participants signed an informed consent form prior to their participation in the study.

: All participant agreed to have their data published for research purposes, given than the data provided was first anonymised.

: All data analysis was carried out using Statistical Package for Social Sciences (SPSS) v. 26.0.